Aroa Biosurgery Limited (Formerly Mesynthes Limited)
New Zealand(FDA 510(k) applicant) Last updated 22 Oct 2026
- Devices
- 3
- Registries
- FDA 510(k)
- FDA recalls
- 0
Catalogue
Endoform Reconstructive Template Ref K153633
Endoform Plastics and Reconstructive Matrix Ref K162461
Endoform Reconstructive Template Ref K153632
What Aroa Biosurgery Limited (Formerly Mesynthes Limited) makes
Aroa Biosurgery Limited manufactures the Endoform Reconstructive Template, a device designed for reconstructive surgical applications, likely used in orthopedic or spinal procedures to support tissue or bone integration.
The company’s portfolio is regulated under FDA 510(k) clearance as Class II devices and is listed in the US regulatory registry. Aroa Biosurgery Limited is based in the United States.
Frequently asked questions
How many devices does Aroa Biosurgery Limited (Formerly Mesynthes Limited) have in the registry?
The registry currently lists 3 devices for Aroa Biosurgery Limited (Formerly Mesynthes Limited). Devices recorded under merged duplicate company entries are counted once.
Which registries list Aroa Biosurgery Limited (Formerly Mesynthes Limited)'s devices?
Among its 3 most recently registered devices, Aroa Biosurgery Limited (Formerly Mesynthes Limited) has devices listed in FDA 510(k) (3 devices).
What risk classes do Aroa Biosurgery Limited (Formerly Mesynthes Limited)'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Aroa Biosurgery Limited (Formerly Mesynthes Limited)'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Aroa Biosurgery Limited (Formerly Mesynthes Limited) in the registry?
The most recently registered devices listed for Aroa Biosurgery Limited (Formerly Mesynthes Limited) include Endoform Reconstructive Template and Endoform Plastics and Reconstructive Matrix.